We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

News   Jul 14, 2020 | Original story from the University of Michigan

 
Single Dose of Tocilizumab Linked to 45% Lower Risk of Dying Among COVID-19 Patients on Ventilators

Credit: Gerd Altmann, Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Russia’s COVID-19 Vaccine “Approved for Mass Production” Despite No Phase III Data

News

The scientific community has been left somewhat perplexed today after Russian President Vladamir Putin announced that Russian authorities have approved the world's first COVID-19 vaccine.

READ MORE

Mouthwash Could Reduce SARS-CoV-2 Short-Term Viral Load, Cell Culture Study Suggests

News

Results from cell culture experiments show that commercially available preparations have an effect on Sars-Cov-2 viruses.

READ MORE

Bacterial Communities Cope Better When Multiple Species Are Present

News

Perturbations in the environment are common, and bacterial communities consisting of several species seem to find their way around the crisis. Species immigration is beneficial for community recovery, an international study shows.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE